Table 2.
Summary table of 42 perturbagens used the zebrafish DASPEI screen.
| Perturbagen name | Vendor (Cat #) | Plate location |
|---|---|---|
| Sirolimus | SelleckChem S1039 | A1 |
| BIIB021 | SelleckChem S1175 | A2 |
| CYT-997 | SelleckChem S2195 | A3 |
| Anisomycin | SelleckChem S7409 | A4 |
| Withaferin-a | Tocris 2816 | A5 |
| BCI-hydrochloride | Sigma B4313 | A6 |
| Arachidonyl-trifluoro-methyl ketone | Tocris 1462 | A7 |
| Trichostatin-A | SelleckChem S1045 | B1 |
| Etoposide | SelleckChem S1225 | B2 |
| Parthenolide | SelleckChem S2341 | B3 |
| Piperlongumine | SelleckChem S7551 | B4 |
| CMPD-1 | Tocris 2186 | B5 |
| Elesclomol | SelleckChem S1052 | C1 |
| Ranolazine | SelleckChem S1425 | C2 |
| Ursolic-acid | SelleckChem S2370 | C3 |
| SB-225002 | SelleckChem S7651 | C4 |
| AEG 3482 | Tocris 2651 | C5 |
| NVP-AUY922 | SelleckChem S1069 | D1 |
| AZD-6482 | SelleckChem S1462 | D2 |
| MG-132 | SelleckChem S2619 | D3 |
| Xanthohumol | SelleckChem S7889 | D4 |
| BNTX maleate | Tocris 0899 | D5 |
| Tanespimycin | SelleckChem S1141 | E1 |
| Disulfiram | SelleckChem S1680 | E2 |
| Fostamatinib | SelleckChem S2625 | E3 |
| Butein | SelleckChem S8036 | E4 |
| Manumycin-A | Sigma 444170-M | E5 |
| Alvespimycin | SelleckChem S1142 | F1 |
| Teniposide | SelleckChem S1787 | F2 |
| Geldanamycin | SelleckChem S2713 | F3 |
| PU-H71 | SelleckChem S8039 | F4 |
| Phenethyl-isothiocyanate | Sigma 253731 | F5 |
| STA-9090 | SelleckChem S1159 | G1 |
| Menadione | SelleckChem S1949 | G2 |
| Pifithrin-μ | SelleckChem S2930 | G3 |
| NSC 632839 | Tocris 2647 | G4 |
| MLN-4924 | EMD Millipore 5.05477.0001 | G5 |
| AT-13387 | SelleckChem S1163 | H1 |
| MLN-2238 | SelleckChem S2180 | H2 |
| PP-1 | SelleckChem S7060 | H3 |
| SA-792709 | Tocris 2020 | H4 |
| Sappanone a dimethyl ether | MicroSource 201136 | H5 |
Table contains the name of each perturbagen compound, the vendor and catalog number of the compound purchased for the screen, and its location on the screening plate used as the stock concentration plate, which was used to determine perturbagen identity after screening.